Detalles de la búsqueda
1.
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.
Gastric Cancer;
27(1): 131-145, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964032
2.
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Gastric Cancer;
24(4): 926-936, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651195
3.
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Gastric Cancer;
24(2): 445-456, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970266
4.
Brain metastases in colorectal cancer: prognostic factors and survival analysis.
Int J Colorectal Dis;
33(11): 1517-1523, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29943356
5.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Br J Cancer;
117(12): 1777-1786, 2017 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29123263
6.
Second-line systemic therapy for metastatic colorectal cancer.
Cochrane Database Syst Rev;
1: CD006875, 2017 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28128439
7.
State of the scientific evidence and recommendations for the management of older patients with gastric cancer.
J Geriatr Oncol;
15(3): 101657, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957106
8.
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Clin Transl Oncol;
2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361134
9.
The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients.
Pharmacogenet Genomics;
23(3): 142-7, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23324806
10.
Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study.
BMC Cancer;
13: 427, 2013 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24053191
11.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Ther Adv Med Oncol;
15: 17588359231157641, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895850
12.
SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021).
Clin Transl Oncol;
24(4): 658-669, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347573
13.
First-Line Maintenance Treatment in Metastatic Colorectal Cancer (mCRC): Quality and Clinical Benefit Overview.
J Clin Med;
10(3)2021 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530547
14.
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial.
Clin Cancer Res;
27(10): 2890-2898, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33727257
15.
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Ther Adv Med Oncol;
13: 17588359211019672, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34211587
16.
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study.
Cancers (Basel);
12(8)2020 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32806731
17.
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).
Cancer Med;
9(3): 1008-1016, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851776
18.
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
PLoS One;
15(7): e0235848, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32735623
19.
Second-line chemotherapy in advanced and metastatic CRC.
Cochrane Database Syst Rev;
(2): CD006875, 2009 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19370656
20.
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial.
JAMA Oncol;
5(11): 1566-1573, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31465088